Ezetimibe Protects Endothelial Cells against Oxidative Stress through Akt/GSK-3β Pathway

Abstract

Ezetimibe was reported to pharmacologically defend against oxidative stress. This study was designed to investigate whether ezetimibe can protect against the oxidative stress induced by oxidized low-density lipoprotein (oxLDL) in vitro and the underlying mechanism. Human umbilical vein endothelial cells (HUVECs) were pretreated with ezetimibe and then exposed to oxLDL for 24 h. TUNEL assay and detectionfor the protein levels of cleaved caspase-3, Bcl-xl and Bcl-2 were employed to assess the oxLDL-induced endothelial apoptosis. Intracellular reactive oxygen species (ROS) generation was evaluated by measuring dichlorofluorescein (DCF) fluorescence. The activities of endothelial antioxidant enzymes [superoxide dismutase (SOD) and catalase] were tested via an enzymatic assay. The mitochondrial membrane potential (MMP) was monitored by flow cytometry using JC-1 staining. Phosphorylation levels of glycogen synthase kinase-3p (p-GSK-3P) and Akt (p-Akt), as well as total GSK-3p and Akt were determined by Western blotting. The results showed that ezetimibe treatment inhibited HUVECs apoptosis, intracellular ROS production, and enhanced antioxidant enzyme activities elicited by oxLDL. HUVECs exposed to oxLDL alone had reduced mitochondrial function, while ezetimibe pre-intervention could significantly rescue the MMP. Furthermore, the protein levels of p-GSK-3p and p-Akt in ezetimibe-pretreated HUVECs were markedly increased as compared with those in oxLDL-induced HUVECs. However, no significant effect on total GSK- 3P and Akt was found in ezetimibe-pretreated HUVECs. Taken together, it was concluded that ezetimibe protects against oxLDL-induced oxidative stress through restoring the MMP, which may be mediated by Akt-dependent GSK-3P phosphorylation.

Keywords

ezetemibe / oxidative stress / mitochondrial dysfunction / Akt/GSK-3β pathway

References

[1] PelusoI, MorabitoG, UrbanL, et al.. Oxidative stress in atherosclerosis development: the central role of LDL and oxidative burst. Endocr Metab Immune Disord Drug Targets, 2012, 12(4): 351-360

[2] MurphySA, CannonCP, BlazingMA, et al.. Reduction in total cardiovascular events with ezetimibe/simvastatin post-acute coronary syndrome: the IMPROVE-IT trial. J Am Coll Cardiol, 2016, 67(4): 353-361

[3] UndasA, MachnikA, PotaczekDP, et al.. Ezetimibe combined with simvastatin compared with simvastatin alone results in a greater suppression of oxidative stress and enhanced fibrinolysis in patients after acute coronary events. J Cardiovasc Pharmacol, 2011, 58(2): 167-172

[4] KostapanosMS, SpyrouAT, TellisCC, et al.. Ezetimibe treatment lowers indicators of oxidative stress in hypercholesterolemic subjects with high oxidative stress. Lipids, 2011, 46(4): 341-348

[5] HughesK, NikolakakiE, PlyteSE, et al.. Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J, 1993, 12(2): 803-808

[6] YaoES, TangY, LiuXH, et al.. TPPU protects tau from H2O2-induced hyperphosphorylation in HEK293/tau cells by regulating PI3K/AKT/GSK-3β pathway. J Huazhong Univ Sei Technolog Med Sei, 2016, 36(6): 785-790

[7] LalH, AhmadF, WoodgettJ, et al.. The GSK-3 family as therapeutic target for myocardial diseases. Circ Res, 2015, 116(1): 138-149

[8] SunagaD, TannoM, KunoA, et al.. Accelerated recovery of mitochondrial membrane potential by GSK-3β inactivation affords cardiomyocytes protection from oxidant-induced necrosis. PLoS One, 2014, 9(11): e112529

[9] QinJ, WangL, LiuZX. Establishement of endothelial cell apoptosis animal model induced by oxidized low density lipoprotein. Chin J Histochem Cytochem, 2003, 12(1): 7-10

[10] QinJ, LiuZX. FAK-related nonkinase attenuates hupertrophy induced by angiotensin-II in cultured neonatal rat cardiac myocytes. Acta Pharmacol Sin, 2006, 27(9): 1159-1164

[11] RueckschlossU, GalleJ, HoltzJ, et al.. Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy. Circulation, 2001, 104(15): 1767-1772

[12] PatelRS, GhasemzadehN, EapenDJ, et al.. Novel biomarker of oxidative stress is associated with risk of death in patients with coronary artery disease. Circulation, 2016, 133(4): 361-369

[13] MunzelT, GoriT, BrunoRM, et al.. Is oxidative stress a therapeutic target in cardiovascular disease. Eur Heart J, 2010, 31(22): 2741-2748

[14] CaiH, HarrisonDG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res, 2000, 87(10): 840-844

[15] DavidsonSM, DuchenMR. Endothelial mitochondria: contributing to vascular function and disease. Circ Res, 2007, 100(8): 1128-1141

[16] ZmijewskiJW, MoelleringD L, GoffeC, et al.. Oxidized LDL induces mitochondrially associated reactive oxygen/nitrogen species formation in endothelial cells. Am J Physiol Heart Circ Physiol, 2005, 289(2): H852-861

[17] TakabeW, LiR, AiL, et al.. Oxidized low-density lipoprotein-actiated c-Jun NH2-terminal kinase regulates manganese superoside dismutase ubiquitination: implication for mitochondrial redox status and apoptosis. Arterioscler Thromb Vase Biol, 2010, 30(3): 436-441

[18] HollvilleE, CarrollRG, CullenSP, et al.. Bcl-2 family proteins participate in mitochondrial quality control by regulating Parkin/PINKl-dependent mitophagy. Mol Cell, 2014, 55(3): 451-466

[19] TiwariSK, SethB, AgarwalS, et al.. Ethosuximide induces hippocampal neurogenesis and reverses cognitive deficits in an Amyloid-β toxin-induced Alzhemimer rat model via the phosphatidylinositol 3-kinase (PI3K)/Akt/Wnt/β-catenin pathway. J Biol Chem, 2015, 290(47): 28540-28558

[20] JimenezE, AriasB, MitjansM, et al.. Association between GSK3β gene and increased impulsivity in bipolar disorder. Eur Neuropsychopharmacol, 2014, 24(4): 510-518

[21] ShinSM, ChoU, KimSG. Resveratrol protects mitochondria against oxidative stress through AMPactivated protein kinase-mediated glycogen synthase kinase-3beta inhibition downstream of poly(ADPribose) polymerase-LKBl pathway. Mol Pharmacol, 2009, 76(4): 884-895

[22] ChengPW, ChenYY, ChengWH, et al.. Wnt signaling regulates blood pressure by downregulating a GSK-3 βmediated pathway to enhance insulin signaling in the central nervous system. Diabetes, 2015, 64(10): 3413-3424